Login to Your Account

Other News To Note

Tuesday, August 21, 2012
• Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., partnered with DPT Laboratories Ltd., of San Antonio, for a supply of Impracor for Phase III trials for musculoskeletal pain. DPT will also carry out work in formulation analysis, validation of quality assurance processes and procedures, and long-term stability testing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription